1 Study Coverage 1.1 Haemophilus b Conjugate Vaccine (Hib) Product Introduction 1.2 Market by Type 1.2.1 Global Haemophilus b Conjugate Vaccine (Hib) Market Size Growth Rate by Type 1.2.2 Inactivated Vaccine 1.2.3 Live Attenuated Vaccine 1.3 Market by Application 1.3.1 Global Haemophilus b Conjugate Vaccine (Hib) Market Size Growth Rate by Application 1.3.2 Government Institution 1.3.3 Private Sector 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Haemophilus b Conjugate Vaccine (Hib) Market Size, Estimates and Forecasts 2.1.1 Global Haemophilus b Conjugate Vaccine (Hib) Revenue 2016-2027 2.1.2 Global Haemophilus b Conjugate Vaccine (Hib) Sales 2016-2027 2.2 Global Haemophilus b Conjugate Vaccine (Hib), Market Size by Region: 2016 VS 2021 VS 2027 2.3 Haemophilus b Conjugate Vaccine (Hib) Historical Market Size by Region (2016-2021) 2.3.1 Global Haemophilus b Conjugate Vaccine (Hib) Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Haemophilus b Conjugate Vaccine (Hib) Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Haemophilus b Conjugate Vaccine (Hib) Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Haemophilus b Conjugate Vaccine (Hib) Sales Forecast by Region (2022-2027) 2.4.2 Global Haemophilus b Conjugate Vaccine (Hib) Revenue Forecast by Region (2022-2027) 3 Global Haemophilus b Conjugate Vaccine (Hib) Competitor Landscape by Players 3.1 Global Top Haemophilus b Conjugate Vaccine (Hib) Manufacturers by Sales 3.1.1 Global Haemophilus b Conjugate Vaccine (Hib) Sales by Manufacturer (2016-2021) 3.1.2 Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Haemophilus b Conjugate Vaccine (Hib) Manufacturers by Revenue 3.2.1 Key Haemophilus b Conjugate Vaccine (Hib) Manufacturers Covered: Ranking by Revenue 3.2.2 Global Haemophilus b Conjugate Vaccine (Hib) Revenue by Manufacturers (2016-2021) 3.2.3 Global Haemophilus b Conjugate Vaccine (Hib) Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Haemophilus b Conjugate Vaccine (Hib) Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Haemophilus b Conjugate Vaccine (Hib) Revenue in 2020 3.2.6 Global Haemophilus b Conjugate Vaccine (Hib) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Haemophilus b Conjugate Vaccine (Hib) Price by Manufacturers 3.4 Global Haemophilus b Conjugate Vaccine (Hib) Manufacturing Base Distribution, Product Types 3.4.1 Haemophilus b Conjugate Vaccine (Hib) Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Haemophilus b Conjugate Vaccine (Hib) Product Type 3.4.3 Date of International Manufacturers Enter into Haemophilus b Conjugate Vaccine (Hib) Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Haemophilus b Conjugate Vaccine (Hib) Market Size by Type (2016-2021) 4.1.1 Global Haemophilus b Conjugate Vaccine (Hib) Sales by Type (2016-2021) 4.1.2 Global Haemophilus b Conjugate Vaccine (Hib) Revenue by Type (2016-2021) 4.1.3 Haemophilus b Conjugate Vaccine (Hib) Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Haemophilus b Conjugate Vaccine (Hib) Market Size Forecast by Type (2022-2027) 4.2.1 Global Haemophilus b Conjugate Vaccine (Hib) Sales Forecast by Type (2022-2027) 4.2.2 Global Haemophilus b Conjugate Vaccine (Hib) Revenue Forecast by Type (2022-2027) 4.2.3 Haemophilus b Conjugate Vaccine (Hib) Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Haemophilus b Conjugate Vaccine (Hib) Market Size by Application (2016-2021) 5.1.1 Global Haemophilus b Conjugate Vaccine (Hib) Sales by Application (2016-2021) 5.1.2 Global Haemophilus b Conjugate Vaccine (Hib) Revenue by Application (2016-2021) 5.1.3 Haemophilus b Conjugate Vaccine (Hib) Price by Application (2016-2021) 5.2 Haemophilus b Conjugate Vaccine (Hib) Market Size Forecast by Application (2022-2027) 5.2.1 Global Haemophilus b Conjugate Vaccine (Hib) Sales Forecast by Application (2022-2027) 5.2.2 Global Haemophilus b Conjugate Vaccine (Hib) Revenue Forecast by Application (2022-2027) 5.2.3 Global Haemophilus b Conjugate Vaccine (Hib) Price Forecast by Application (2022-2027) 6 United States by Players, Type and Application 6.1 United States Haemophilus b Conjugate Vaccine (Hib) Market Size YoY Growth 2016-2027 6.1.1 United States Haemophilus b Conjugate Vaccine (Hib) Sales YoY Growth 2016-2027 6.1.2 United States Haemophilus b Conjugate Vaccine (Hib) Revenue YoY Growth 2016-2027 6.1.3 United States Haemophilus b Conjugate Vaccine (Hib) Market Share in Global Market 2016-2027 6.2 United States Haemophilus b Conjugate Vaccine (Hib) Market Size by Players (International and Local Players) 6.2.1 United States Top Haemophilus b Conjugate Vaccine (Hib) Players by Sales (2016-2021) 6.2.2 United States Top Haemophilus b Conjugate Vaccine (Hib) Players by Revenue (2016-2021) 6.3 United States Haemophilus b Conjugate Vaccine (Hib) Historic Market Review by Type (2016-2021) 6.3.1 United States Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Type (2016-2021) 6.3.2 United States Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Type (2016-2021) 6.3.3 United States Haemophilus b Conjugate Vaccine (Hib) Price by Type (2016-2021) 6.4 United States Haemophilus b Conjugate Vaccine (Hib) Market Estimates and Forecasts by Type (2022-2027) 6.4.1 United States Haemophilus b Conjugate Vaccine (Hib) Sales Forecast by Type (2022-2027) 6.4.2 United States Haemophilus b Conjugate Vaccine (Hib) Revenue Forecast by Type (2022-2027) 6.4.3 United States Haemophilus b Conjugate Vaccine (Hib) Price Forecast by Type (2022-2027) 6.5 United States Haemophilus b Conjugate Vaccine (Hib) Historic Market Review by Application (2016-2021) 6.5.1 United States Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Application (2016-2021) 6.5.2 United States Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Application (2016-2021) 6.5.3 United States Haemophilus b Conjugate Vaccine (Hib) Price by Application (2016-2021) 6.6 United States Haemophilus b Conjugate Vaccine (Hib) Market Estimates and Forecasts by Application (2022-2027) 6.6.1 United States Haemophilus b Conjugate Vaccine (Hib) Sales Forecast by Application (2022-2027) 6.6.2 United States Haemophilus b Conjugate Vaccine (Hib) Revenue Forecast by Application (2022-2027) 6.6.3 United States Haemophilus b Conjugate Vaccine (Hib) Price Forecast by Application (2022-2027) 7 North America 7.1 North America Haemophilus b Conjugate Vaccine (Hib) Market Size YoY Growth 2016-2027 7.2 North America Haemophilus b Conjugate Vaccine (Hib) Market Facts & Figures by Country 7.2.1 North America Haemophilus b Conjugate Vaccine (Hib) Sales by Country (2016-2021) 7.2.2 North America Haemophilus b Conjugate Vaccine (Hib) Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Haemophilus b Conjugate Vaccine (Hib) Market Size YoY Growth 2016-2027 8.2 Asia Pacific Haemophilus b Conjugate Vaccine (Hib) Market Facts & Figures by Region 8.2.1 Asia Pacific Haemophilus b Conjugate Vaccine (Hib) Sales by Region (2016-2021) 8.2.2 Asia Pacific Haemophilus b Conjugate Vaccine (Hib) Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Haemophilus b Conjugate Vaccine (Hib) Market Size YoY Growth 2016-2027 9.2 Europe Haemophilus b Conjugate Vaccine (Hib) Market Facts & Figures by Country 9.2.1 Europe Haemophilus b Conjugate Vaccine (Hib) Sales by Country (2016-2021) 9.2.2 Europe Haemophilus b Conjugate Vaccine (Hib) Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Haemophilus b Conjugate Vaccine (Hib) Market Size YoY Growth 2016-2027 10.2 Latin America Haemophilus b Conjugate Vaccine (Hib) Market Facts & Figures by Country 10.2.1 Latin America Haemophilus b Conjugate Vaccine (Hib) Sales by Country (2016-2021) 10.2.2 Latin America Haemophilus b Conjugate Vaccine (Hib) Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Market Facts & Figures by Country 11.2.1 Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Sales by Country (2016-2021) 11.2.2 Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 Sanofi Pasteur, SA 12.1.1 Sanofi Pasteur, SA Corporation Information 12.1.2 Sanofi Pasteur, SA Description and Business Overview 12.1.3 Sanofi Pasteur, SA Haemophilus b Conjugate Vaccine (Hib) Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Sanofi Pasteur, SA Haemophilus b Conjugate Vaccine (Hib) Products Offered 12.1.5 Sanofi Pasteur, SA Recent Development 12.2 GSK 12.2.1 GSK Corporation Information 12.2.2 GSK Description and Business Overview 12.2.3 GSK Haemophilus b Conjugate Vaccine (Hib) Sales, Revenue and Gross Margin (2016-2021) 12.2.4 GSK Haemophilus b Conjugate Vaccine (Hib) Products Offered 12.2.5 GSK Recent Development 12.3 Merck 12.3.1 Merck Corporation Information 12.3.2 Merck Description and Business Overview 12.3.3 Merck Haemophilus b Conjugate Vaccine (Hib) Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Merck Haemophilus b Conjugate Vaccine (Hib) Products Offered 12.3.5 Merck Recent Development 12.11 Sanofi Pasteur, SA 12.11.1 Sanofi Pasteur, SA Corporation Information 12.11.2 Sanofi Pasteur, SA Description and Business Overview 12.11.3 Sanofi Pasteur, SA Haemophilus b Conjugate Vaccine (Hib) Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Sanofi Pasteur, SA Haemophilus b Conjugate Vaccine (Hib) Products Offered 12.11.5 Sanofi Pasteur, SA Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Haemophilus b Conjugate Vaccine (Hib) Industry Trends 13.2 Haemophilus b Conjugate Vaccine (Hib) Market Drivers 13.3 Haemophilus b Conjugate Vaccine (Hib) Market Challenges 13.4 Haemophilus b Conjugate Vaccine (Hib) Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Haemophilus b Conjugate Vaccine (Hib) Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Haemophilus b Conjugate Vaccine (Hib) Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Inactivated Vaccine Table 3. Major Manufacturers of Live Attenuated Vaccine Table 4. Global Haemophilus b Conjugate Vaccine (Hib) Market Size Growth Rate by Application (2021-2027) & (K Doses) Table 5. Global Haemophilus b Conjugate Vaccine (Hib) Market Size by Region (K Doses) & (US$ Million), 2016 VS 2021 VS 2027 Table 6. Global Haemophilus b Conjugate Vaccine (Hib) Sales by Regions (2016-2021) & (K Doses) Table 7. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Regions (2016-2021) Table 8. Global Haemophilus b Conjugate Vaccine (Hib) Revenue by Regions (2016-2021) & (US$ Million) Table 9. Global Haemophilus b Conjugate Vaccine (Hib) Sales Forecast by Region (2022-2027) & (K Doses) Table 10. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share Forecast by Region (2022-2027) Table 11. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Forecast by Region (2022-2027) & (US$ Million) Table 12. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share Forecast by Region (2022-2027) Table 13. Global Haemophilus b Conjugate Vaccine (Hib) Sales by Manufacturers (2016-2021) (K Doses) Table 14. Global Haemophilus b Conjugate Vaccine (Hib) Sales Share by Manufacturers (2016-2021) Table 15. Ranking of Global Top Haemophilus b Conjugate Vaccine (Hib) Manufacturers by Revenue (US$ Million) in 2020 Table 16. Haemophilus b Conjugate Vaccine (Hib) Revenue by Manufacturers (2016-2021) (US$ Million) Table 17. Haemophilus b Conjugate Vaccine (Hib) Revenue Share by Manufacturers (2016-2021) Table 18. Global Haemophilus b Conjugate Vaccine (Hib) Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 19. Global Haemophilus b Conjugate Vaccine (Hib) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Haemophilus b Conjugate Vaccine (Hib) as of 2020) Table 20. Key Manufacturers Haemophilus b Conjugate Vaccine (Hib) Price (2016-2021) (US$/Dose) Table 21. Haemophilus b Conjugate Vaccine (Hib) Manufacturers Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Haemophilus b Conjugate Vaccine (Hib) Product Type Table 23. Date of International Manufacturers Enter into Haemophilus b Conjugate Vaccine (Hib) Market Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans Table 25. Global Haemophilus b Conjugate Vaccine (Hib) Sales by Type (2016-2021) (K Doses) Table 26. Global Haemophilus b Conjugate Vaccine (Hib) Sales Share by Type (2016-2021) Table 27. Global Haemophilus b Conjugate Vaccine (Hib) Revenue by Type (2016-2021) (US$ Million) Table 28. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Share by Type (2016-2021) Table 29. Haemophilus b Conjugate Vaccine (Hib) Average Selling Price (ASP) by Type (2016-2021) & (US$/Dose) Table 30. Global Haemophilus b Conjugate Vaccine (Hib) Sales Forecast by Type (2022-2027) & (K Doses) Table 31. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share Forecast by Type (2022-2027) Table 32. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Forecast V (2022-2027) & (US$ Million) Table 33. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share Forecast by Type (2022-2027) Table 34. Global Haemophilus b Conjugate Vaccine (Hib) Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Dose) Table 35. Global Haemophilus b Conjugate Vaccine (Hib) Sales by Application (2016-2021) (K Doses) Table 36. Global Haemophilus b Conjugate Vaccine (Hib) Sales Share by Application (2016-2021) Table 37. Global Haemophilus b Conjugate Vaccine (Hib) Revenue by Application (2016-2021) (US$ Million) Table 38. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Share by Application (2016-2021) Table 39. Haemophilus b Conjugate Vaccine (Hib) Average Selling Price (ASP) by Application (2016-2021) & (US$/Dose) Table 40. Global Haemophilus b Conjugate Vaccine (Hib) Sales Forecast by Application (2022-2027) & (K Doses) Table 41. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share Forecast by Application (2022-2027) Table 42. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Forecast by Application (2022-2027) & (US$ Million) Table 43. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share Forecast by Application (2022-2027) Table 44. Global Haemophilus b Conjugate Vaccine (Hib) Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Dose) Table 45. United States Haemophilus b Conjugate Vaccine (Hib) Sales (K Doses) of Key Companies (2016-2021) Table 46. United States Haemophilus b Conjugate Vaccine (Hib) Sales Share by Company (2016-2021) Table 47. United States Haemophilus b Conjugate Vaccine (Hib) Revenue (US$ Million) by Company (2016-2021) Table 48. United States Haemophilus b Conjugate Vaccine (Hib) Revenue Share by Company (2016-2021) Table 49. United States Haemophilus b Conjugate Vaccine (Hib) Sales (K Doses) by Type (2016-2021) Table 50. United States Haemophilus b Conjugate Vaccine (Hib) Sales Share by Type (2016-2021) Table 51. United States Haemophilus b Conjugate Vaccine (Hib) Revenue (US$ Million) Market Share by Type (2016-2021) Table 52. United States Haemophilus b Conjugate Vaccine (Hib) Price (US$/Dose) by Type (2016-2021) Table 53. United States Haemophilus b Conjugate Vaccine (Hib) Sales (K Doses) by Type (2022-2027) Table 54. United States Haemophilus b Conjugate Vaccine (Hib) Sales Share by Type (2022-2027) Table 55. United States Haemophilus b Conjugate Vaccine (Hib) Revenue (US$ Million) Market Share by Type (2022-2027) Table 56. United States Haemophilus b Conjugate Vaccine (Hib) Revenue Share by Type (2022-2027) Table 57. United States Haemophilus b Conjugate Vaccine (Hib) Price (US$/Dose) by Type (2022-2027) Table 58. United States Haemophilus b Conjugate Vaccine (Hib) Sales (K Doses) by Application (2016-2021) Table 59. United States Haemophilus b Conjugate Vaccine (Hib) Sales Share by Application (2016-2021) Table 60. United States Haemophilus b Conjugate Vaccine (Hib) Revenue (US$ Million) Market Share by Application (2016-2021) Table 61. United States Haemophilus b Conjugate Vaccine (Hib) Price (US$/Dose) by Application (2016-2021) Table 62. United States Haemophilus b Conjugate Vaccine (Hib) Sales (K Doses) by Application (2022-2027) Table 63. United States Haemophilus b Conjugate Vaccine (Hib) Sales Share by Application (2022-2027) Table 64. United States Haemophilus b Conjugate Vaccine (Hib) Revenue (US$ Million) Market Share by Application (2022-2027) Table 65. United States Haemophilus b Conjugate Vaccine (Hib) Revenue Share by Application (2022-2027) Table 66. United States Haemophilus b Conjugate Vaccine (Hib) Price (US$/Dose) by Application (2022-2027) Table 67. North America Haemophilus b Conjugate Vaccine (Hib) Sales by Country (2016-2021) & (K Doses) Table 68. North America Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Country (2016-2021) Table 69. North America Haemophilus b Conjugate Vaccine (Hib) Revenue by Country (2016-2021) & (US$ Million) Table 70. North America Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Country (2016-2021) Table 71. Asia Pacific Haemophilus b Conjugate Vaccine (Hib) Sales by Region (2016-2021) & (K Doses) Table 72. Asia Pacific Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Region (2016-2021) Table 73. Asia Pacific Haemophilus b Conjugate Vaccine (Hib) Revenue by Region (2016-2021) & (US$ Million) Table 74. Asia Pacific Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Region (2016-2021) Table 75. Europe Haemophilus b Conjugate Vaccine (Hib) Sales by Country (2016-2021) & (K Doses) Table 76. Europe Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Country (2016-2021) Table 77. Europe Haemophilus b Conjugate Vaccine (Hib) Revenue by Country (2016-2021) & (US$ Million) Table 78. Europe Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Country (2016-2021) Table 79. Latin America Haemophilus b Conjugate Vaccine (Hib) Sales by Country (2016-2021) & (K Doses) Table 80. Latin America Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Country (2016-2021) Table 81. Latin Americaa Haemophilus b Conjugate Vaccine (Hib) Revenue by Country (2016-2021) & (US$ Million) Table 82. Latin America Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Country (2016-2021) Table 83. Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Sales by Country (2016-2021) & (K Doses) Table 84. Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Country (2016-2021) Table 85. Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Revenue by Country (2016-2021) & (US$ Million) Table 86. Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Country (2016-2021) Table 87. Sanofi Pasteur, SA Corporation Information Table 88. Sanofi Pasteur, SA Description and Business Overview Table 89. Sanofi Pasteur, SA Haemophilus b Conjugate Vaccine (Hib) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021) Table 90. Sanofi Pasteur, SA Haemophilus b Conjugate Vaccine (Hib) Product Table 91. Sanofi Pasteur, SA Recent Development Table 92. GSK Corporation Information Table 93. GSK Description and Business Overview Table 94. GSK Haemophilus b Conjugate Vaccine (Hib) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021) Table 95. GSK Product Table 96. GSK Recent Development Table 97. Merck Corporation Information Table 98. Merck Description and Business Overview Table 99. Merck Haemophilus b Conjugate Vaccine (Hib) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021) Table 100. Merck Product Table 101. Merck Recent Development Table 102. Haemophilus b Conjugate Vaccine (Hib) Market Trends Table 103. Haemophilus b Conjugate Vaccine (Hib) Market Drivers Table 104. Haemophilus b Conjugate Vaccine (Hib) Market Challenges Table 105. Haemophilus b Conjugate Vaccine (Hib) Market Restraints Table 106. Haemophilus b Conjugate Vaccine (Hib) Customers List Table 107. Haemophilus b Conjugate Vaccine (Hib) Distributors List Table 108. Research Programs/Design for This Report Table 109. Key Data Information from Secondary Sources Table 110. Key Data Information from Primary Sources List of Figures Figure 1. Haemophilus b Conjugate Vaccine (Hib) Product Picture Figure 2. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Type in 2020 & 2027 Figure 3. Inactivated Vaccine Product Picture Figure 4. Live Attenuated Vaccine Product Picture Figure 5. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Application in 2020 & 2027 Figure 6. Government Institution Figure 7. Private Sector Figure 8. Other Figure 9. Haemophilus b Conjugate Vaccine (Hib) Report Years Considered Figure 10. Global Haemophilus b Conjugate Vaccine (Hib) Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Haemophilus b Conjugate Vaccine (Hib) Market Size 2016-2027 (US$ Million) Figure 12. Global Haemophilus b Conjugate Vaccine (Hib) Sales 2016-2027 (K Doses) Figure 13. Global Haemophilus b Conjugate Vaccine (Hib) Market Size Market Share by Region: 2021 Versus 2027 Figure 14. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Region (2016-2021) Figure 15. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Region in 2020 Figure 16. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Region (2016-2021) Figure 17. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Region in 2020 Figure 18. Global Haemophilus b Conjugate Vaccine (Hib) Sales Share by Manufacturer in 2020 Figure 19. The Top 10 and 5 Players Market Share by Haemophilus b Conjugate Vaccine (Hib) Revenue in 2020 Figure 20. Haemophilus b Conjugate Vaccine (Hib) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 21. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Type (2016-2021) Figure 22. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Type in 2020 Figure 23. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Type (2016-2021) Figure 24. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Type in 2020 Figure 25. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Application (2016-2021) Figure 26. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Application in 2020 Figure 27. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Application (2016-2021) Figure 28. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Application in 2020 Figure 29. United States Haemophilus b Conjugate Vaccine (Hib) Sales Growth Rate 2016-2027 (K Doses) Figure 30. United States Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate 2016-2027 (US$ Million) Figure 31. United States Haemophilus b Conjugate Vaccine (Hib) Market Share in Global Market 2016-2027 Figure 32. United States 5 and 10 Largest Haemophilus b Conjugate Vaccine (Hib) Players Market Share by Revenue in Haemophilus b Conjugate Vaccine (Hib) in 2020 Figure 33. United States Haemophilus b Conjugate Vaccine (Hib) Revenue Share by Type (2016-2021) Figure 34. United States Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate by Type in 2016 & 2020 Figure 35. United States Haemophilus b Conjugate Vaccine (Hib) Revenue Share by Application (2016-2021) Figure 36. United States Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate by Application in 2016 & 2020 Figure 37. North America Haemophilus b Conjugate Vaccine (Hib) Sales Growth Rate 2016-2021 (K Doses) Figure 38. North America Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate 2016-2021 (US$ Million) Figure 39. North America Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Country in 2020 Figure 40. North America Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Country in 2020 Figure 41. U.S. Haemophilus b Conjugate Vaccine (Hib) Sales Growth Rate (2016-2021) (K Doses) Figure 42. U.S. Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Canada Haemophilus b Conjugate Vaccine (Hib) Sales Growth Rate (2016-2021) (K Doses) Figure 44. Canada Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Europe Haemophilus b Conjugate Vaccine (Hib) Sales Growth Rate 2016-2021 (K Doses) Figure 46. Europe Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate 2016-2021 (US$ Million) Figure 47. Europe Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Country in 2020 Figure 48. Europe Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Country in 2020 Figure 49. Germany Haemophilus b Conjugate Vaccine (Hib) Sales Growth Rate (2016-2021) (K Doses) Figure 50. Germany Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2016-2021) (US$ Million) Figure 51. France Haemophilus b Conjugate Vaccine (Hib) Sales Growth Rate (2016-2021) (K Doses) Figure 52. France Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2016-2021) (US$ Million) Figure 53. U.K. Haemophilus b Conjugate Vaccine (Hib) Sales Growth Rate (2016-2021) (K Doses) Figure 54. U.K. Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2016-2021) (US$ Million) Figure 55. Italy Haemophilus b Conjugate Vaccine (Hib) Sales Growth Rate (2016-2021) (K Doses) Figure 56. Italy Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2016-2021) (US$ Million) Figure 57. Russia Haemophilus b Conjugate Vaccine (Hib) Sales Growth Rate (2016-2021) (K Doses) Figure 58. Russia Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2016-2021) (US$ Million) Figure 59. Asia Pacific Haemophilus b Conjugate Vaccine (Hib) Sales Growth Rate 2016-2021 (K Doses) Figure 60. Asia Pacific Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate 2016-2021 (US$ Million) Figure 61. Asia Pacific Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Region in 2020 Figure 62. Asia Pacific Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Region in 2020 Figure 63. China Haemophilus b Conjugate Vaccine (Hib) Sales Growth Rate (2016-2021) (K Doses) Figure 64. China Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2016-2021) (US$ Million) Figure 65. Japan Haemophilus b Conjugate Vaccine (Hib) Sales Growth Rate (2016-2021) (K Doses) Figure 66. Japan Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2016-2021) (US$ Million) Figure 67. South Korea Haemophilus b Conjugate Vaccine (Hib) Sales Growth Rate (2016-2021) (K Doses) Figure 68. South Korea Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2016-2021) (US$ Million) Figure 69. India Haemophilus b Conjugate Vaccine (Hib) Sales Growth Rate (2016-2021) (K Doses) Figure 70. India Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2016-2021) (US$ Million) Figure 71. Australia Haemophilus b Conjugate Vaccine (Hib) Sales Growth Rate (2016-2021) (K Doses) Figure 72. Australia Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2016-2021) (US$ Million) Figure 73. Taiwan Haemophilus b Conjugate Vaccine (Hib) Sales Growth Rate (2016-2021) (K Doses) Figure 74. Taiwan Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2016-2021) (US$ Million) Figure 75. Indonesia Haemophilus b Conjugate Vaccine (Hib) Sales Growth Rate (2016-2021) (K Doses) Figure 76. Indonesia Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2016-2021) (US$ Million) Figure 77. Thailand Haemophilus b Conjugate Vaccine (Hib) Sales Growth Rate (2016-2021) (K Doses) Figure 78. Thailand Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2016-2021) (US$ Million) Figure 79. Malaysia Haemophilus b Conjugate Vaccine (Hib) Sales Growth Rate (2016-2021) (K Doses) Figure 80. Malaysia Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2016-2021) (US$ Million) Figure 81. Philippines Haemophilus b Conjugate Vaccine (Hib) Sales Growth Rate (2016-2021) (K Doses) Figure 82. Philippines Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2016-2021) (US$ Million) Figure 83. Vietnam Haemophilus b Conjugate Vaccine (Hib) Sales Growth Rate (2016-2021) (K Doses) Figure 84. Vietnam Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2016-2021) (US$ Million) Figure 85. Latin America Haemophilus b Conjugate Vaccine (Hib) Sales Growth Rate 2016-2021 (K Doses) Figure 86. Latin America Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate 2016-2021 (US$ Million) Figure 87. Latin America Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Country in 2020 Figure 88. Latin America Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Country in 2020 Figure 89. Mexico Haemophilus b Conjugate Vaccine (Hib) Sales Growth Rate (2016-2021) (K Doses) Figure 90. Mexico Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2016-2021) (US$ Million) Figure 91. Brazil Haemophilus b Conjugate Vaccine (Hib) Sales Growth Rate (2016-2021) (K Doses) Figure 92. Brazil Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2016-2021) (US$ Million) Figure 93. Argentina Haemophilus b Conjugate Vaccine (Hib) Sales Growth Rate (2016-2021) (K Doses) Figure 94. Argentina Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2016-2021) (US$ Million) Figure 95. Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Sales Growth Rate 2016-2021 (K Doses) Figure 96. Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate 2016-2021 (US$ Million) Figure 97. Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Country in 2020 Figure 98. Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Country in 2020 Figure 99. Turkey Haemophilus b Conjugate Vaccine (Hib) Sales Growth Rate (2016-2021) (K Doses) Figure 100. Turkey Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2016-2021) (US$ Million) Figure 101. Saudi Arabia Haemophilus b Conjugate Vaccine (Hib) Sales Growth Rate (2016-2021) (K Doses) Figure 102. Saudi Arabia Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2016-2021) (US$ Million) Figure 103. UAE Haemophilus b Conjugate Vaccine (Hib) Sales Growth Rate (2016-2021) (K Doses) Figure 104. UAE Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate (2016-2021) (US$ Million) Figure 105. Haemophilus b Conjugate Vaccine (Hib) Value Chain Figure 106. Channels of Distribution Figure 107. Distributors Profiles Figure 108. Bottom-up and Top-down Approaches for This Report Figure 109. Data Triangulation Figure 110. Key Executives Interviewed

Sanofi Pasteur, SA GSK Merck